Integer (NYSE:ITGR) Issues FY 2026 Earnings Guidance

Integer (NYSE:ITGR) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 5.830-6.400 for the period, compared to the consensus EPS estimate of 6.490. The company issued revenue guidance of $1.8 billion-$1.8 billion, compared to the consensus revenue estimate of $1.8 billion.

Integer Stock Down 5.6%

Shares of Integer stock traded down $4.92 during trading on Friday, hitting $83.59. 480,005 shares of the stock traded hands, compared to its average volume of 739,675. The firm has a market cap of $2.85 billion, a P/E ratio of 29.14, a price-to-earnings-growth ratio of 1.42 and a beta of 0.71. The company has a current ratio of 3.32, a quick ratio of 2.23 and a debt-to-equity ratio of 0.69. Integer has a 52-week low of $62.00 and a 52-week high of $126.86. The stock’s fifty day simple moving average is $86.07 and its 200 day simple moving average is $81.76.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, April 30th. The medical equipment provider reported $1.20 EPS for the quarter, missing the consensus estimate of $1.21 by ($0.01). Integer had a net margin of 5.55% and a return on equity of 13.26%. The firm had revenue of $439.58 million for the quarter, compared to analysts’ expectations of $426.48 million. During the same quarter in the prior year, the business posted $1.31 EPS. The business’s quarterly revenue was up .5% on a year-over-year basis. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. On average, equities analysts predict that Integer will post 6.47 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the company. Truist Financial raised their price objective on Integer from $95.00 to $97.00 and gave the stock a “buy” rating in a research note on Friday, February 20th. Weiss Ratings upgraded Integer from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday, February 24th. Raymond James Financial restated an “outperform” rating and issued a $101.00 price objective on shares of Integer in a research note on Monday, February 23rd. Wall Street Zen cut Integer from a “buy” rating to a “hold” rating in a research note on Sunday, January 25th. Finally, Wells Fargo & Company raised their price objective on Integer from $72.00 to $84.00 and gave the stock an “equal weight” rating in a research note on Friday, February 20th. Four equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, Integer currently has a consensus rating of “Hold” and an average price target of $98.71.

Insider Activity at Integer

In other news, VP Tommy P. Thomas sold 825 shares of the business’s stock in a transaction that occurred on Friday, March 13th. The stock was sold at an average price of $85.00, for a total value of $70,125.00. Following the completion of the sale, the vice president directly owned 4,381 shares in the company, valued at $372,385. The trade was a 15.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.10% of the stock is owned by company insiders.

Key Headlines Impacting Integer

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Revenue and organic growth beat expectations — Q1 sales were roughly $440M (up 0.5% year-over-year) with 1.3% organic growth, driven by strength across key product lines. This topline beat is supporting optimism on demand recovery. ITGR Stock Up Despite Q1 Earnings Missing Estimates, Revenues Rise Y/Y
• Neutral Sentiment: Board has initiated a strategic review to “maximize stockholder value” (including possible sale, merger or other combinations). A review can unlock value but also creates execution and process uncertainty; outcomes are binary and timing is unclear. Integer Announces Strategic Review to Maximize Stockholder Value
• Neutral Sentiment: Company published the full Q1 release, slide deck and held its earnings call (transcript and presentation available). These materials provide detail on segment trends and margin drivers for investors doing deeper diligence. Integer Holdings Corporation 2026 Q1 – Results – Earnings Call Presentation
• Neutral Sentiment: Trading was temporarily halted pre-market on the day of the release for “news pending,” which typically increases short-term volume and volatility once resumed. Integer Announces Strategic Review to Maximize Stockholder Value
• Negative Sentiment: EPS missed consensus by a penny — reported $1.20 vs. $1.21 expected — and year-over-year EPS declined from $1.31, reflecting margin pressure that investors are watching closely. Integer (ITGR) Q1 Earnings Lag Estimates
• Negative Sentiment: FY 2026 EPS guidance was set to $5.83–$6.40, below the consensus (~$6.49), which raises investor concern about margin recovery and near-term earnings growth — a key reason for today’s downside pressure. Integer Q1 2026 Press Release / Guidance

Institutional Trading of Integer

A number of institutional investors have recently made changes to their positions in the company. T. Rowe Price Investment Management Inc. boosted its stake in shares of Integer by 800,382.9% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 280,169 shares of the medical equipment provider’s stock worth $21,974,000 after acquiring an additional 280,134 shares during the last quarter. Corient Private Wealth LLC acquired a new stake in Integer in the 4th quarter valued at about $535,000. Mercer Global Advisors Inc. ADV raised its holdings in Integer by 1.4% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 41,049 shares of the medical equipment provider’s stock valued at $3,219,000 after acquiring an additional 555 shares during the last quarter. XTX Topco Ltd acquired a new stake in Integer in the 4th quarter valued at about $4,581,000. Finally, Voloridge Investment Management LLC acquired a new stake in Integer in the 4th quarter valued at about $14,694,000. 99.29% of the stock is owned by institutional investors and hedge funds.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.